43 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
20 Jul 23
Maravai LifeSciences Announces Appointment of New Director to the Board
4:08pm
experience guiding organizations to achieve significant scale.”
Dr. Jessica Hopfield, Chair of the Nominating, Governance and Risk Committee of Maravai’s … Board, said, “Director succession planning is an important part of Maravai’s corporate governance, and John’s appointment is the result of a robust
DEF 14A
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Apr 21
Definitive proxy
4:46pm
COMMONLY ASKED QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING
BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
PROPOSAL 1—ELECTION OF DIRECTORS
EXECUTIVE … at Maravai’s principal executive offices.
BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
Our business and affairs are managed under the direction of our
PRE 14A
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Apr 21
Preliminary proxy
4:16pm
COMMONLY ASKED QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING
BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
PROPOSAL 1—ELECTION OF DIRECTORS
EXECUTIVE … at Maravai’s principal executive offices.
BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
Our business and affairs are managed under the direction of our
8-K
EX-99.1
8uvow72
10 Nov 21
Maravai Lifesciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance for 2022
4:09pm
424B4
f7he2dvil of72gqon
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
379w1h ov
25 Mar 21
Draft registration statement
12:00am
424B4
c7km6baggswisaa rtc1
13 Sep 21
Prospectus supplement with pricing info
4:16pm
DRS
hkyc ehv3
26 Aug 21
Draft registration statement
12:00am
424B4
dizybgcg4n5c0bf5
23 Nov 20
Prospectus supplement with pricing info
4:36pm
DRS
xke4by
8 Sep 20
Draft registration statement
12:00am
DRS/A
5se3aju0 gwo
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
p6dgy3qar3 pwj
29 Oct 20
IPO registration
5:04pm
DRS/A
qubzk2
23 Oct 20
Draft registration statement (amended)
12:00am
8-K
EX-99.1
uy6ettk9
8 May 23
Maravai Lifesciences Reports First Quarter 2023 Financial Results
4:09pm